In addition, we have also shown that hepatic STAMP2 alleviates polychlorinated biphenyl (PCB)-induced steatosis in NAFLD in in vivo and in vitro models [28]. This evidence concerns the gene STEAP4 and metabolic dysfunction-associated steatotic liver disease.